Almeida, Orlandino
Almeida, Orlandino was paid $49K by Medicaid between Mar 2019 and Nov 2024, across 7 billing codes. Its largest line is 78452, Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress — 53% of everything it billed.
33Billing provider infoALMEIDA, ORLANDINO
BROOKLYN, NY 11201
BROOKLYN, NY 11201
33aNPI1992742266assigned 06/02/2006
33bProvider typeSpecialist
28Total paid$49K
24GClaims1,257
24DCodes billed7
24AFirst – last monthMar 2019 – Nov 2024
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#596 of 1,221
Median peer was paid$45K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 70 | $2K | |
| 2020 | 194 | $8K | |
| 2021 | 416 | $15K | |
| 2022 | 129 | $4K | |
| 2023 | 255 | $6K | |
| 2024incomplete | 193 | $15K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 53% | 145 | 145 | $26K |
| 93015 | 29% | 421 | 420 | $14K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 9.0% | 225 | 223 | $4K |
| 93000 | 4.9% | 291 | 289 | $2K | |
| J2785 | Injection, regadenoson, 0.1 mg | 3.3% | 147 | 147 | $2K |
| 78306 | <1% | 13 | 13 | $285.62 | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | <1% | 15 | 14 | $52.71 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.